Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00618605
First received: February 18, 2008
Last updated: October 31, 2016
Last verified: October 2016